Answer
In vitro studies show that brigatinib is primarily metabolised by CYP2C8 and CYP3A4, and to a much lesser extent by CYP3A5.
Sources for this answer
- Alunbrig 30 mg film-coated tabletsTakeda UK Ltd · emc · SmPC §5.2 Pharmacokinetic properties · Version 11Document updated
Sources checked